Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options

P Tanna, RW Strauss, K Fu**ami… - British Journal of …, 2017 - bjo.bmj.com
Stargardt disease (STGD1; MIM 248200) is the most prevalent inherited macular dystrophy
and is associated with disease-causing sequence variants in the gene ABCA4. Significant …

Phenoty** and genoty** inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod …

M Georgiou, AG Robson, K Fu**ami… - Progress in retinal and …, 2024 - Elsevier
Inherited retinal diseases (IRD) are a leading cause of blindness in the working age
population and children. The scope of this review is to familiarise clinicians and scientists …

Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease

KJ Carss, G Arno, M Erwood, J Stephens… - The American Journal of …, 2017 - cell.com
Inherited retinal disease is a common cause of visual impairment and represents a highly
heterogeneous group of conditions. Here, we present findings from a cohort of 722 …

[HTML][HTML] Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells in macular degeneration

MS Mehat, V Sundaram, C Ripamonti, AG Robson… - Ophthalmology, 2018 - Elsevier
Purpose Transplantation of human embryonic stem cell (hESC)-derived retinal pigment
epithelial (RPE) cells offers the potential for benefit in macular degeneration. Previous trials …

Cellular mechanisms of hereditary photoreceptor degeneration–Focus on cGMP

M Power, S Das, K Schütze, V Marigo, P Ekström… - Progress in Retinal and …, 2020 - Elsevier
The cellular mechanisms underlying hereditary photoreceptor degeneration are still poorly
understood, a problem that is exacerbated by the enormous genetic heterogeneity of this …

[HTML][HTML] Endpoints for clinical trials in ophthalmology

L Schmetterer, H Scholl, G Garhöfer… - Progress in Retinal and …, 2023 - Elsevier
With the identification of novel targets, the number of interventional clinical trials in
ophthalmology has increased. Visual acuity has for a long time been considered the gold …

[HTML][HTML] Clinical and molecular characteristics of childhood-onset Stargardt disease

K Fu**ami, J Zernant, RK Chana, GA Wright… - Ophthalmology, 2015 - Elsevier
Purpose To describe the clinical and molecular characteristics of patients with childhood-
onset Stargardt disease (STGD). Design Retrospective case series. Participants Forty-two …

Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options

N Rahman, M Georgiou, KN Khan… - British Journal of …, 2020 - bjo.bmj.com
Macular dystrophies (MDs) consist of a heterogeneous group of disorders that are
characterised by bilateral symmetrical central visual loss. Advances in genetic testing over …

Early-onset stargardt disease: phenotypic and genotypic characteristics

S Lambertus, RAC van Huet, NM Bax, LH Hoefsloot… - Ophthalmology, 2015 - Elsevier
Objective To describe the phenotype and genotype of patients with early-onset Stargardt
disease. Design Retrospective cohort study. Participants Fifty-one Stargardt patients with …

[HTML][HTML] A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations

K Fu**ami, N Lois, R Mukherjee… - … & visual science, 2013 - jov.arvojournals.org
Purpose.: We characterized subtypes of fundus autofluorescence (AF) and the progression
of retinal atrophy, and correlated these findings with genotype in Stargardt disease …